Cary Street Partners Investment Advisory’s Vanguard Health Care ETF VHT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,977
Closed -$558K 763
2024
Q3
$558K Sell
1,977
-123
-6% -$34.2K 0.02% 473
2024
Q2
$559K Buy
2,100
+20
+1% +$5.24K 0.02% 446
2024
Q1
$563K Buy
2,080
+251
+14% +$65.9K 0.02% 436
2023
Q4
$459K Buy
1,829
+127
+7% +$30.1K 0.02% 439
2023
Q3
$400K Buy
1,702
+385
+29% +$93.8K 0.02% 430
2023
Q2
$322K Buy
1,317
+313
+31% +$76.1K 0.02% 427
2023
Q1
$239K Hold
1,004
0.02% 441
2022
Q4
$249K Buy
1,004
+100
+11% +$24.2K 0.02% 431
2022
Q3
$202K Buy
904
+159
+21% +$38K 0.02% 450
2022
Q2
$175K Buy
+745
New +$180K 0.01% 436
2020
Q4
Sell
-509
Closed -$104K 851
2020
Q3
$104K Buy
+509
New +$103K 0.02% 372

Other funds holding VHT

Cary Street Partners Investment Advisory's VHT Position: Q4 2024 in Review

Cary Street Partners Investment Advisory sold out of Vanguard Health Care ETF (VHT) in Q4 2024, closing a stake of 1,977 shares — an estimated $558K sold.

Cary Street Partners Investment Advisory first reported a position in VHT in Q3 2020 and held it in 11 quarters. The position peaked at $563K in Q1 2024. 1,055 funds tracked by Wall St. Rank hold VHT as of Q4 2024.

  • Cary Street Partners Investment Advisory reported no remaining Vanguard Health Care ETF position as of Q4 2024 after selling out during the quarter.
  • Cary Street Partners Investment Advisory sold 1,977 Vanguard Health Care ETF shares in Q4 2024, an estimated $558K.
  • Cary Street Partners Investment Advisory first reported a position in Vanguard Health Care ETF in Q3 2020 and held it in 11 quarters.
  • Cary Street Partners Investment Advisory's Vanguard Health Care ETF position peaked at $563K in Q1 2024.
  • 1,055 funds tracked by Wall St. Rank held Vanguard Health Care ETF as of Q4 2024.

Based on Cary Street Partners Investment Advisory's 13F filing for Q4 2024, filed 14 Feb 2025.